Compare OXBR & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OXBR | EVGN |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | Cayman Islands | Israel |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 9.0M |
| IPO Year | 2014 | N/A |
| Metric | OXBR | EVGN |
|---|---|---|
| Price | $1.25 | $1.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $3.50 |
| AVG Volume (30 Days) | 12.0K | ★ 46.4K |
| Earning Date | 11-06-2025 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,423,000.00 | ★ $8,016,000.00 |
| Revenue This Year | $497.99 | N/A |
| Revenue Next Year | $42.14 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.19 |
| 52 Week Low | $1.12 | $0.95 |
| 52 Week High | $5.81 | $2.42 |
| Indicator | OXBR | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 34.88 | 40.59 |
| Support Level | $1.17 | $0.96 |
| Resistance Level | $1.30 | $1.06 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 3.23 | 26.05 |
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer. It provides reinsurance solutions through its subsidiary. It focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. Oxbridge specializes in underwriting medium frequency, high severity risks, where insufficient data exists to analyze effectively the risk/return profile of reinsurance contracts. The company manages its business on the basis of one operating segment, Property and Casualty Reinsurance.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.